🇺🇸 FDA
Patent

US 11370769

TRPC5 inhibitors and methods of using same

granted A61PA61P13/12

Quick answer

US patent 11370769 (TRPC5 inhibitors and methods of using same) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P13/12